SUN ANTHONY Y
Known title: President & CEOCIK: 0001377952
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Hyperion DeFi Launches Institutional Credit and Data Feed Deals. Hyperion DeFi announced the rollout of its first institutional credit facility on the Aviya Finance platform. The company also agreed to assist DoubleZero in deploying commercially available Hyperliquid data feeds. These moves signal a push toward broader institutional adoption and new revenue streams for the firm.
Transaction History
| ZNTL | ▼ Sell | Open Market | 7,971 | $409K | 4/5/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 2,500 | $130K | 4/5/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 10,471 | $508K | 4/4/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 9,771 | $490K | 3/2/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 700 | $36K | 3/2/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 8,771 | $436K | 3/1/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 1,700 | $85K | 3/1/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 4,208 | $211K | 2/14/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 525 | $27K | 2/14/2022 | View on chart |
| ZNTL | ▲ Buy | Grant | 50,431 | $0 | 2/10/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 8,128 | $470K | 2/2/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 2,343 | $137K | 2/2/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 4,124 | $234K | 2/1/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 3,419 | $197K | 2/1/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 2,828 | $166K | 2/1/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 100 | $6K | 2/1/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 2,000 | $155K | 1/4/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 6,871 | $541K | 1/4/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 1,556 | $124K | 1/4/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 44 | $4K | 1/4/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 2,573 | $201K | 1/3/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 1,125 | $89K | 1/3/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 1,108 | $90K | 1/3/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 993 | $82K | 1/3/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 300 | $25K | 1/3/2022 | View on chart |
| ZNTL | ▼ Sell | Open Market | 4,372 | $351K | 1/3/2022 | View on chart |
| ZNTL | ▼ Sell | Gift | 15,000 | $0 | 12/16/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 311 | $23K | 12/2/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 1,289 | $95K | 12/2/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 600 | $45K | 12/2/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 500 | $38K | 12/2/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 3,824 | $296K | 12/2/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 124 | $10K | 12/2/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 3,823 | $298K | 12/2/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 1,548 | $114K | 12/1/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 800 | $61K | 12/1/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 2,700 | $217K | 12/1/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 104 | $8K | 12/1/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 396 | $31K | 12/1/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 500 | $39K | 12/1/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 921 | $68K | 12/1/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 3,502 | $279K | 12/1/2021 | View on chart |
| ZNTL | ▼ Sell | Gift | 125,000 | $0 | 11/26/2021 | View on chart |
| ZNTL | ▼ Sell | Gift | 125,000 | $0 | 11/26/2021 | View on chart |
| HYPD | ▲ Buy | Grant | 6,963 | $0 | 11/17/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 1,494 | $119K | 11/2/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 5,180 | $416K | 11/2/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 3,797 | $308K | 11/2/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 2,600 | $214K | 11/1/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 200 | $17K | 11/1/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 4,420 | $357K | 11/1/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 3,251 | $265K | 11/1/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 10,464 | $690K | 10/4/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 16,308 | $1.1M | 10/4/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 27 | $2K | 10/4/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 13,482 | $914K | 9/1/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 825 | $57K | 9/1/2021 | View on chart |
| ZNTL | ▼ Sell | Open Market | 12,487 | $838K | 9/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Leerink Partners initiates coverage of Zentalis at Outperform
Leerink Partners has begun covering Zentalis Pharmaceuticals with an Outperform rating and a price target of $8. This new analyst note places the target above the current average analyst estimate of $6.89. The move adds to the recent analyst activity surrounding the stock, which is currently trading near its 52-week range midpoint.
Leerink Partners initiates coverage of Zentalis at Outperform. Leerink Partners has begun covering Zentalis Pharmaceuticals with an Outperform rating and a price target of $8. This new analyst note places the target above the current average analyst estimate of $6.89. The move adds to the recent analyst activity surrounding the stock, which is currently trading near its 52-week range midpoint.